07:30 a.m. – 08:20 a.m.

Registration

8:20 a.m. – 8:30 a.m.

Opening
Rodrigo Munhoz, Fábio de Oliveira Ferreira e Francisco Belfort

8:30 a.m. – 8:45 a.m.

Revisiting the evidences and alternatives for photoprotection
Speaker: Sérgio Schalka

8:45 a.m. – 9:00 a.m.

The role of molecular pathology in differentiating pigmented lesions
Speaker: Gilles Landman

9:00 a.m. – 9:15 a.m.

Dermatology insights: how not to miss the diagnosis of a melanoma?
Speaker: Flávia Bittencourt

9:15 a.m. – 9:30 a.m.

Integrating non-invasive techniques in the diagnosis of melanocytic lesions
Speaker: Juliana Casagrande

9:30 a.m.– 9:45 a.m.

When a patient with skin cancer should seek genetic counseling?
Speaker: Maria Isabel Achatz

9:45 a.m. – 9:55 a.m.

Discussion / Q&A

9:55 a.m. – 10:15 a.m.

Interval

10:15 a.m. – 10:30 a.m.

Tips and tricks for the appropriate management of lentigo
Speaker: André Molina

10:30 a.m. – 10:45 a.m.

Current adjuvant treatment options for high-risk stage II melanoma and future perspectives
Speaker: Veridiana Pires de Camargo

10:45 a.m. – 11:05 a.m.

Debate: Now that we can treat high-risk stage II melanoma, should we perform SLN biopsy for this patient population?
Yes vs. No
Clinical Case: Marcello Queiroz
Yes: Eduardo Bertolli
No: Felice Riccardi

11:05 a.m. – 11:20 a.m.

Sentinel LN biopsy in melanoma of the scalp/head and neck – controversies and recommendations
Speaker: Vernon Sondak

11:20 a.m. – 11:35 a.m.

Intralesional therapies in melanoma – updates and perspectives
Speaker: Sandra Wong

11:35 a.m. – 11:50 a.m.

Stage III melanoma – shoot first and ask later?
Speaker: Axel Hauschild

11:50 a.m. – 12:00 p.m.

Discussion/ Q&A

12:00 p.m. – 12:45:00 p.m.

Satellite Symposium MERCK & PFIZER
Real Life Experience Treating Long-Term Merkel Patients
Speakers: Rodrigo Munhoz and Marina Sahad

12:45 p.m. – 1:30 p.m.

Satellite Symposium MSD*
Adjuvance in Melanoma: Controversial Aspects and Perspectives
Speaker: Rodrigo Villaroel
*Este Simpósio será exibido apenas para prescritores.

1:30 p.m. – 2:00 p.m.

Interval

2:00 p.m. – 2:20 p.m.

Plenary 1 - Melanoma screening status – are we overdiagnosing in situ melanoma?
Speaker: Vernon Sondak

2:20 p.m. – 2:40 p.m.

Plenary 2 - Dermoscopy to aid in early melanoma identification: the yin-yang
Speaker: Ashfaq Marghoob

2:40 p.m. – 3:00 p.m.

Plenary 3 - Dermoscopy algorithms in challenging skin tumors – a critical analysis
Speaker: Ashfaq Marghoob

3:00 p.m. – 3:20 p.m.

Clinical conundrum: Treatment duration in patients with advanced cutaneous malignancies receiving ICP - does one size fit all?
Speaker: Axel Hauschild

3:20 p.m. – 3:30 p.m.

Roundtable and Q&A

3:30 p.m. – 3:45 p.m.

Current status of the first-line treatment in advanced melanoma
Speaker: Rodrigo Rovere

3:45 p.m. – 4:00 p.m.

Optimizing the benefit from ICP: DOs and DON’Ts
Speaker: Allan Pereira

4:00 p.m. – 4:15 p.m.

Debate: oligometastatic melanoma – surgery first vs systemic treatment first
Clinical case: Beatriz Awni
Surgery first: Alberto Wainstein
Systemic treatment first: Douglas Johnson

4:15 p.m. – 4:30 p.m.

Treatment beyond progression to first-line therapy in melanoma: what choices do we have?
Speaker: Milton Barros

4:30 p.m. – 4:40 p.m.

Discussion / Q&A

4:40 p.m. – 4:55 p.m.

Current indications of systemic therapies in SCC
Speaker: Rodrigo Guedes

4:55 p.m. – 5:10 p.m.

Treatment algorithms for patients with high-risk BCC
Speaker: Flávio Cavarsan

5:10 p.m. – 5:30 p.m.

Roundtable - Merkel cell carcinoma - What is the optimal treatment for patients with MCC with and without nodal involvement?
Clinical case: Yuri Bittencourt
1- Vernon Sondak
2- João Duprat
3- Robson Ferrigno
4- Rodrigo Villaroel

5:30 p.m. – 5:45 p.m.

Merkel cell carcinoma - Advances in systemic treatments over the past years
Speaker: Andreia Melo

5:45 p.m. – 6:00 p.m.

Cutaneous lymphomas - Initial approach and what to avoid?
Speaker: Jade Cury

6:00 p.m. – 6:10 p.m.

Discussion / Q&A

6:10 p.m.

Closure

8:30 a.m. – 8:45 a.m.

Ophthalmology: when to suspect and how to diagnose ocular malignancies?
Speaker: Rubens Belfort Netto

8:45 a.m. – 9:00 a.m.

Endocrinology: Vitamin D, sun exposure and skin cancers – myths and facts
Speaker: Luciana Audi

9:00 a.m. – 9:15 a.m.

Geriatric medicine: geriatric assessment in the treatment of patients with skin cancer – weighing risks and benefits in the elderly population?
Speaker: Theodora Karnakis

9:15 a.m. – 9:30 a.m.

Debate: will AI replace the dermatologist? Yes vs No
Yes: Maurício Mendonça
No: Ana Maria Sortino

9:30 a.m. – 9:45 a.m.

Discussion / Q&A

9:45 a.m. – 10:30 a.m.

Satellite Symposium BMS*
Melanoma IO treatment: current and future therapies
Speaker: Rodrigo Munhoz
*Este Simpósio será exibido apenas para prescritores.

10:30 a.m. – 10:50 a.m.

Plenary 4 - Surgery with microscopically controlled margins – current status in melanoma, BCC and SCC
Speaker: Sandra Wong

10:50 a.m.– 11:10 a.m.

Plenary 5 - Tackling the microbiome: where are we?
Speaker: Douglas Johnson

11:10 a.m. – 11:30 a.m.

Plenary 6 - Alternatives beyond steroids in cutaneous immune-related adverse events
Speaker: Cristina Abdalla

11:30 a.m. – 11:40 a.m.

Roundtable and Q&A

11:40 a.m. – 12:25 p.m.

Satellite Symposium SANOFI
Real World Evidence with Cemiplimabe – Advance in Advanced Non-Melanoma Skin Cancer
Speaker: Rodrigo Rovere

12:25 p.m. – 12:45 p.m.

Roundtable: Approach high-risk keratinocyte carcinomas in the immunocompromised patient
Clinical case: Catalina Gavilanes
1. Renato Bakos
2. Samir Hanna
3. Miguel Brandão
4. Luiza Dib

12:45 p.m. – 1:00 p.m.

Dermatologic monitoring and follow of the immunocompromised patient
Speaker: Carolina Atallah

1:00 p.m. – 1:15 p.m.

Systemic therapies in immunocompromised patients and transplant recipients
Speaker: Douglas Johnson

1:15 p.m. – 1:25 p.m.

Discussion / Q&A

1:25 p.m. - 1:30 p.m.

Closure